Drug Trial Radar · NCT01001975
Determination of Sun Protection in Sunscreen Formulas (Study SR09-15)(P08236)(COMPLETED)
Last checked: Nov 19, 2026Latest source record: Mar 11, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Jul 2009
Primary completion
Aug 2009
Study completion Aug 2009
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- First posted
- Oct 27, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Study to determine the sunscreen protection factor (SPF) and ultraviolet A protection factor (PFA) of 2 sunscreen products containing the combination of zinc oxide and avobenzone with and without ensulizole.
Conditions
- Sun Protection
Interventions
Sunscreen Test Code: V53-028Drug
Sunscreen formula containing 15% Zinc Oxide, 3% Avobenzone, and 1% Ensulizole
Sunscreen Test Code: V53-030Drug
Sunscreen formula containing 15% Zinc Oxide and 3% Avobenzone
Standard SPF 4 SunscreenDrug
8% Homosalate Standard SPF 4 Sunscreen
Primary outcomes
What the sponsor says the trial is designed to measure.
- Determination of Sunscreen Protection Factor (SPF)Time frame: 16 to 24 hours post-exposure
- Determination of Ultraviolet A Protection Factor (PFA)Time frame: 2 to 4 hours post-exposure
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.